277 Safety and efficacy of intratumoral ipilimumab with IV nivolumab in metastatic melanoma. The NIVIPIT trial

Bibliographic Details
Title: 277 Safety and efficacy of intratumoral ipilimumab with IV nivolumab in metastatic melanoma. The NIVIPIT trial
Authors: Jean-Yves Scoazec, Francois-Xavier Danlos, Caroline Robert, Aurélien Marabelle, Celeste Lebbe, Laurence Zitvogel, Stephane Dalle, Samy Ammari, Lambros Tselikas, Nicolas Meyer, Severine Roy, Camille Jannin, Siham Farhane, Severine Mourad, Guillaume Escriou, Thibault Raoult, Matthieuu Texier, Nathalie Chaput-Gras, Thierry De Baere
Source: Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Publisher Information: BMJ Publishing Group, 2021.
Publication Year: 2021
Collection: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Subject Terms: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2051-1426
Relation: https://doaj.org/toc/2051-1426
DOI: 10.1136/jitc-2021-SITC2021.277
Access URL: https://doaj.org/article/78678ec2bc3a45e3873985b6da7763da
Accession Number: edsdoj.78678ec2bc3a45e3873985b6da7763da
Database: Directory of Open Access Journals
More Details
ISSN:20511426
DOI:10.1136/jitc-2021-SITC2021.277
Published in:Journal for ImmunoTherapy of Cancer
Language:English